Grant: CIHR Fellowship
Direct Payment
$150,000.00
Lysine Methylation of Non-Histone Proteins
EF 2008-09
Résumé
In order to confine the human genome inside the nucleus, the cell has to compact 1.8meter of DNA inside a 6micron diameter space. To achieve this level of compaction, small proteins known as histones help the formation and organisation of the genome into chromatin and chromosomes. This extensive compaction of the genetic material put an incredible constraint on the availability of the genetic information. In order to regulate the genetic information accessibility, the histones are temporally and spacially modified by small molecules, which facilitate the timely compaction or relaxation of discreet regions of DNA. One such histone modification, lysine methylation (Kme), is laid down by lysine methyltranferase (KMT) enzymes. Several KMTs have clear links to cancer, suggesting a central role for this modification in maintaining cellular homeostasis and in neoplastic disease. Dynamic Kme of histone proteins regulates diverse cellular functions. In contrast, the biological functions of Kme on non-histone proteins, while rapidly evolving, is largely unexplored. Accumulating evidence suggests that small protein domains are involved in specific recognition and readout of the methyl marks. The field of Kme of non-histone proteins, still in its infancy, lacks the "tools" to easily and efficiently identify novel KMT substrates and sensors of this modification. I have therefore been involved in the development of a proteomic approach, using click chemistry, to identify by an unbiased approach additional KMT substrates. In parallel, I have developped an impartial screening method to identify novel sensors of Kme events. I plan to advance the study of the biological functions of novel protein Kme events that I have identified on a family of chromatin regulators and tumour suppressor proteins named ING, with the goal of elucidating how disruption in this signalling mark can trigger a pathologic state.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
California, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
176017
Name
Binda Olivier
Region
California
Country
United States of America
Orgtype
Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Lysine Methylation of Non-Histone Proteins
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Chromatin; Histone; Lysine Methylation; Lysine Methyltransferase; Non-Histone Proteins; Protein-Protein Interaction
Abstract
In order to confine the human genome inside the nucleus, the cell has to compact 1.8meter of DNA inside a 6micron diameter space. To achieve this level of compaction, small proteins known as histones help the formation and organisation of the genome into chromatin and chromosomes. This extensive compaction of the genetic material put an incredible constraint on the availability of the genetic information. In order to regulate the genetic information accessibility, the histones are temporally and spacially modified by small molecules, which facilitate the timely compaction or relaxation of discreet regions of DNA. One such histone modification, lysine methylation (Kme), is laid down by lysine methyltranferase (KMT) enzymes. Several KMTs have clear links to cancer, suggesting a central role for this modification in maintaining cellular homeostasis and in neoplastic disease. Dynamic Kme of histone proteins regulates diverse cellular functions. In contrast, the biological functions of Kme on non-histone proteins, while rapidly evolving, is largely unexplored. Accumulating evidence suggests that small protein domains are involved in specific recognition and readout of the methyl marks. The field of Kme of non-histone proteins, still in its infancy, lacks the "tools" to easily and efficiently identify novel KMT substrates and sensors of this modification. I have therefore been involved in the development of a proteomic approach, using click chemistry, to identify by an unbiased approach additional KMT substrates. In parallel, I have developped an impartial screening method to identify novel sensors of Kme events. I plan to advance the study of the biological functions of novel protein Kme events that I have identified on a family of chromatin regulators and tumour suppressor proteins named ING, with the goal of elucidating how disruption in this signalling mark can trigger a pathologic state.
Competitiondate
200810
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Binda, Olivier
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~